LONDON–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank">#Biotechnology</a>–The global female sexual dysfunction treatment market is expected to post a CAGR close to 37% during the period 2019-2023, according to Technavio.

Source link